Osteoporosis and its implications for dental patients

被引:19
作者
Edwards, Beatrice J. [1 ]
Migliorati, Cesar A. [2 ]
机构
[1] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
[2] Nova SE Univ, Coll Dent Med, Ft Lauderdale, FL 33314 USA
关键词
aging; his phosphonate-associated osteonecrosis; bone loss; decision making; dental care for chronically ill patients; dental care for elderly patients; drug therapy;
D O I
10.14219/jada.archive.2008.0214
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Background. Osteoporosis is a common disease disease in middle-aged and older-Americans. The risk of sustaining fractures is a concern and mortality rates C after hip or vertebral fractures are high. Oral health maintenance for adults with osteoporosis is important. Types off Studies Reviewed. The authors conducted a MEDLINE search of the medical and dental literature with the objective of reviewing osteoporosis, its effect on public health in the population in the United States and the implications in providing dental care for these patients. They selected studies by performing a content search with National Library of Medicine medical, subject headings (epidemiology, public health impact, treatment, Adverse drug reactions, cost-effectiveness of osteoporosis therapy, oral health, periodontal disease, adverse drug reactions, bisphosphonates and osteonecrosis of the jaw). They then performed a study design search with a filter so that only randomized clinical trials were included. Results. Osteoporosis and related fractures are more common than coronary disease, stroke and breast cancer. Fractures resulting from osteoporosis can affect a patient's quality of life severely, and fractures result in functional impairment and-increased health care cost and mortality. Medical management of osteoporosis includes diet control, with appropriate intake of calcium and vitamin D, weight-bearing exercise, discontinuation of tobacco and alcohol intake, and use of medications, including selective estrogen receptor modulators, calcitonin, anabolic agents and bisphosphohates. Bisphosphonates have been associated with the development of osteonecrosis of the jaws. Clinical Implications. Oral health maintenance is important in patients with osteoporosis. Bisphosphonate therapy or other medical treatment for these people should be discontinued only after consultation with the patient's physician.
引用
收藏
页码:545 / 552
页数:8
相关论文
共 81 条
[1]  
*AM DENT ASS COUNC, 2006, J AM DENT ASSOC, V137, P1144
[2]  
[Anonymous], 2004, Bone Health and Osteoporosis: A report of the Surgeon General
[3]  
[Anonymous], 1995, Osteoporosis: Etiology, Diagnosis, and Management
[4]   Calcium accretion in girls and boys during puberty: A longitudinal analysis [J].
Bailey, DA ;
Heather, ADM ;
McKay, HA ;
Whiting, S ;
Mirwald, R .
JOURNAL OF BONE AND MINERAL RESEARCH, 2000, 15 (11) :2245-2250
[5]   Broadband ultrasound attenuation predicts fractures strongly and independently of densitometry in older women - A prospective study [J].
Bauer, DC ;
Gluer, CC ;
Cauley, JA ;
Vogt, TM ;
Ensrud, KE ;
Genant, HK ;
Black, DM .
ARCHIVES OF INTERNAL MEDICINE, 1997, 157 (06) :629-634
[6]   Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis [J].
Black, Dennis M. ;
Delmas, Pierre D. ;
Eastell, Richard ;
Reid, Ian R. ;
Boonen, Steven ;
Cauley, Jane A. ;
Cosman, Felicia ;
Lakatos, Peter ;
Leung, Ping Chung ;
Man, Zulema ;
Mautalen, Carlos ;
Mesenbrink, Peter ;
Hu, Huilin ;
Caminis, John ;
Tong, Karen ;
Rosario-Jansen, Theresa ;
Krasnow, Joel ;
Hue, Trisha F. ;
Sellmeyer, Deborah ;
Eriksen, Erik Fink ;
Cummings, Steven R. .
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (18) :1809-1822
[7]   Effects of continuing or stopping alendronate after 5 years of treatment - The Fracture Intervention Trial long-term extension (FLEX): A randomized trial [J].
Black, Dennis M. ;
Schwartz, Ann V. ;
Ensrud, Kristine E. ;
Cauley, Jane A. ;
Levis, Silvina ;
Quandt, Sara A. ;
Satterfield, Suzanne ;
Wallace, Robert B. ;
Bauer, Douglas C. ;
Palermo, Lisa ;
Wehren, Lois E. ;
Lombardi, Antonio ;
Santora, Arthur C. ;
Cummings, Steven R. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (24) :2927-2938
[8]   Ten years' experience with alendronate for osteoporosis in postmenopausal women [J].
Bone, HG ;
Hosking, D ;
Devogelaer, J ;
Tucci, JR ;
Emkey, RD ;
Tonino, RP ;
Rodriguez-Portales, JA ;
Downs, RW ;
Gupta, J ;
Santora, AC ;
Liberman, UA .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (12) :1189-1199
[9]   The effect of risedronate on bone mineralization as measured by micro-computed tomography with synchrotron radiation: Correlation to histomorphometric indices of turnover [J].
Borah, B ;
Ritman, EL ;
Dufresne, TE ;
Jorgensen, SM ;
Liu, S ;
Sacha, J ;
Phipps, RJ ;
Turner, RT .
BONE, 2005, 37 (01) :1-9
[10]   A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study [J].
Chesnut, CH ;
Silverman, S ;
Andriano, K ;
Genant, H ;
Gimona, A ;
Harris, S ;
Kiel, D ;
LeBoff, M ;
Maricic, M ;
Miller, P ;
Moniz, C ;
Peacock, M ;
Richardson, P ;
Watts, N ;
Baylink, D .
AMERICAN JOURNAL OF MEDICINE, 2000, 109 (04) :267-276